ISOVUE 300 612 mg/mL (Iopamidol INJECTION, SOLUTION) 612 mg/mL

Iopamidol 612 mg/mL injection solution for intravenous use. A radiocontrast agent for diagnostic imaging procedures. Essential for enhancing visibility in X-ray and CT scans.

Strength

612 mg/mL

Pack Size

10 BOTTLE in 1 BOX (0270-1315-35) / 100 mL in 1 BOTTLE

Manufacturer / TM Owner

Bracco Diagnostics Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Iopamidol is a contrast medium primarily used in medical imaging to improve the visibility of internal structures during X-ray and CT scans. It is commonly administered intravenously to help diagnose conditions related to blood vessels, organs, and tissues. This solution is designed to provide clear imaging results, aiding healthcare professionals in identifying abnormalities or areas of concern.

Side Effects

Iopamidol may cause temporary side effects such as a warm sensation, nausea, or a metallic taste in the mouth. These effects are generally mild and short-lived. Severe reactions are rare but can include allergic responses or changes in heart rate and blood pressure.

Precautions & Warnings

Iopamidol should be used with caution in individuals with a history of allergic reactions to contrast media. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper hydration is often recommended before and after the procedure.

Avoid Interactions

Iopamidol may interact with certain medications, particularly those affecting kidney function or blood pressure. It is advisable to discuss all current medications with a healthcare provider before undergoing a procedure involving iopamidol. Alcohol and other substances that affect hydration levels should be avoided.

Frequently Asked Questions

Iopamidol is used as a contrast agent to enhance the visibility of internal structures during X-ray and CT scans.

Iopamidol is typically administered intravenously by a healthcare professional during diagnostic imaging procedures.

Common side effects may include a warm sensation, nausea, or a metallic taste in the mouth.

Iopamidol should be used with caution in patients with kidney problems, and proper hydration is often recommended.

Individuals with a history of allergic reactions to contrast media should inform their healthcare provider before using iopamidol.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.